Archbold Oncologist Received Award for Clinical Leadership
Georgia hematologist Josh Simmons was recognized for expanding patient access to blood cancer clinical trials.
Updated on Oct. 13, 2026 in Cancer
Live Poll
Do you believe local hospitals should prioritize hosting clinical trials to reduce patient travel needs?
Hematologist Josh Simmons of Archbold Cancer Center received an award from the Georgia Blood Cancer Trials Network for his work in clinical trial leadership. This initiative aims to improve regional patient access to oncology research.
Why it matters
Expanding clinical trial availability within community practices allows patients to access potential treatments without needing to travel to large academic hubs. This effort is critical for ensuring more Georgians can participate in cutting-edge hematology research closer to home.
The award recognized leadership within the Georgia Blood Cancer Trials Network, a collaborative effort across state oncology practices. The impact of these regional research programs is still under investigation regarding long-term patient enrollment outcomes.
The players
Josh Simmons
A hematologist and oncologist at Archbold Cancer Center specializing in blood cancers.
Georgia Blood Cancer Trials Network
A collaborative state-wide organization focused on expanding clinical trial access for blood cancer patients.
Archbold Cancer Center
A medical facility in Thomasville that provides cancer care and research opportunities to residents of southwest Georgia.
Johnathon Cohen
A researcher at Emory University Winship Cancer Institute who presented the leadership award.
The details
The Georgia Blood Cancer Trials Network coordinates research efforts across hospitals and independent practices to centralize trial infrastructure. By participating in these research groups, local centers like Archbold Cancer Center can host trials that might otherwise be exclusive to distant academic centers. This model is designed to lower geographic barriers, allowing residents in southwest Georgia to remain in their community while receiving care that aligns with evolving oncological standards.
Timeline
October 12, 2026: Josh Simmons received the award at the Didactics in Hematology and Oncology Conference.
Health Landscape
The Georgia Blood Cancer Trials Network represents a shift toward decentralized clinical research models that prioritize regional equity. This approach mirrors national efforts to integrate community oncology practices into the broader framework of high-level cancer research.
If you are managing a blood cancer diagnosis, discussing clinical trial options with your oncologist is a valuable step to explore potential treatment pathways. Patients at Archbold Cancer Center can reach the oncology staff at 229-584-5400 to inquire about current study eligibility.
The takeaway
The growth of regional trial networks is a promising sign for patient access to advanced oncology treatments in local settings. Consider asking your physician if a clinical trial might be a suitable component of your current care plan.
Further reading
Learn more about local efforts to improve outcomes in our Cancer section.
Source note: This article includes information reported by Thomasville Times-Enterprise.
Live Poll
Do you believe local hospitals should prioritize hosting clinical trials to reduce patient travel needs?
